09

2026

-

11

Bringing Together Industry Expertise to Usher in a New Chapter for Dairy Enterprises — The Golden Key for Dairy Cows · Aolong Bio Special Seminar Was Successfully Held in Rongchang!

Author:


On November 6, 2026, the “Dairy Cow Golden Key · Aolong Bio Special Seminar,” co-hosted by the Dairy Cow Golden Key Technical Service Alliance and Chongqing Aolong Biological Products Co., Ltd. (hereinafter referred to as Aolong Bio), was grandly held in Rongchang, Chongqing, at the China Animal Husbandry Science and Technology City. With the theme “Gathering Industry Expertise to Usher in a New Chapter for Dairy Enterprises,” the seminar focused on pressing pain points in dairy production and featured in-depth discussions on cutting-edge theory, farm operations, precision prevention and control, disease eradication, biosecurity, and digital‑intelligent transformation. The event not only provided practical, feasible technical solutions to challenges faced by producers but also fostered communication and collaboration among all stakeholders across the industry chain, supporting a transition from a “single immunization model” to an “integrated prevention and control system.” This effort aims to build momentum for improving quality and efficiency, and for achieving green, sustainable, high‑quality development in China’s dairy sector.

Prior to the official start of the Dairy Cow Golden Key · Aolong Bio Special Seminar, participating experts and guests jointly toured Aolong Bio’s exhibition hall and production facilities.

Professor Li Shengli of China Agricultural University and former chief scientist of the National Dairy Cattle Industry Technology System; Zhang Xue, vice president and chief technical engineer of Modern Dairy (Group) Co., Ltd. and a group-level science and technology expert under the State-owned Assets Supervision and Administration Commission of the State Council’s “Ten-Hundred-Thousand” program; Yang Hongjun, researcher at the Shandong Academy of Agricultural Sciences, post scientist in the Disease Control Laboratory, and former deputy chief of the National Dairy Cattle Industry Technology System; Li Jianxi, deputy director of the Lanzhou Institute of Husbandry and Veterinary Medicine of the Chinese Academy of Agricultural Sciences and director of the Disease Prevention and Control Laboratory within the National Modern Dairy Industry Technology System; Professor Zhou Yulong of Heilongjiang Bayi Agricultural Reclamation University and provincial chief technologist; Pan Zihao, master’s supervisor at Nanjing Agricultural University and member of the Dairy Livestock Welfare and Health Management Committee of the China Dairy Association; and Yang Zhanshan, deputy secretary-general of the Digital Dairy Golden Key Technical Service Alliance—along with other leading experts and scholars—attended to provide guidance. Nearly 200 people were present, including executives from top national dairy companies, farm managers, distributor representatives, and production technicians from Aolong Bio. Additionally, 15,500 viewers tuned in simultaneously via a live stream hosted by “Dairy Cow Micro‑View.”

Fu Gang, General Manager of Chongqing Aolong Biological Products Co., Ltd., delivered a welcome address to the conference. He noted that the dairy industry is a strategic sector vital to both national economy and people’s livelihoods, and that the foundation of high-quality raw milk lies in healthy herds, with biosecurity systems serving as its core support. As China’s dairy industry accelerates its transformation and upgrading, the era of relying solely on single-product supply is now behind us. Faced with multiple challenges—including disease risks, rising farming costs, and the need for more sophisticated farm management—the industry urgently requires scientific, practical, and replicable integrated solutions for healthy livestock production.

Fu Gang, General Manager of Aolong Bio, delivered a welcome address.

Fu Gang emphasized that Aolong Bio positions itself not merely as a product supplier, but as a long-term partner in the healthy farming of livestock. Over its 17 years of operation, the company has focused on animal health for ruminants, specializing in the R&D, production, and technical services of disease prevention and control products for cattle and sheep. It remains committed to driving deep integration among industry, academia, and research through technological innovation, continuously developing safe, effective, and stable vaccines and associated diagnostic products. The company has established a dedicated technical service team that works directly on farms, implementing targeted solutions to address on-site challenges such as optimizing immunization protocols, establishing biosecurity systems, and conducting disease monitoring and early warning. This effort translates laboratory research into tangible production benefits for farmers.

Fu Gang stated that he hopes this seminar will serve as a bridge for exchange, establishing a platform for mutual learning, shared insights, and coordinated collaboration. By relying on science-based pandemic prevention to safeguard the dairy industry’s safety and leveraging technological empowerment to drive industrial upgrading, all parties can jointly explore pathways toward sustainable, high-quality development of China’s dairy sector.

Li Shengli, professor at China Agricultural University and former chief scientist of the National Dairy Cattle Industry Technology System, delivered a speech.

In his address, Professor Li Shengli of China Agricultural University and former Chief Scientist of the National Dairy Cattle Industry Technology System said that Aolong Bio’s standardized and rigorous production controls had left a deep impression on him. He also fully commended Aolong Bio for its solid achievements and extensive experience in vaccine quality control, market reputation, and extending technical services to the front lines.

He pointed out that disease prevention and control has always been the top priority in farm management, more critical to survival than nutrition or breeding. From emergency response to Foot-and-Mouth Disease Type I in South Africa, to eradication efforts for brucellosis and tuberculosis, and to comprehensive, routine control of diseases like BVDV and IBR, each example underscores that biosecurity capabilities directly determine the resilience of industry development. He emphasized that, especially during this recovery window, preventive measures must take precedence. This symposium brought together system-level scientists, leading animal health companies, major livestock groups, and the Golden Key Alliance, among other key stakeholders. It is hoped that this high‑level forum will serve as a bridge to translate farms’ real needs into R&D priorities, turning laboratory breakthroughs into tangible improvements in yield, incidence rates, and profitability, thereby developing better products tailored to Chinese dairy cows and ruminants, and jointly supporting the high‑quality, sustainable development of China’s dairy sector.

Pan Zihao, a master’s supervisor at Nanjing Agricultural University and a member of the Dairy Cattle Welfare and Health Management Committee of the China Dairy Industry Association, delivered a keynote report titled “Analysis of Infectious Disease Detection Data and Research on Emerging Pathogens in Large-Scale Dairy Farms.”

At the seminar, Pan Zihao, a master’s supervisor at Nanjing Agricultural University and a member of the Dairy Cattle Welfare and Health Management Committee of the China Dairy Industry Association, delivered a keynote presentation titled “Analysis of Infectious Disease Detection Data and Research on Emerging Pathogens in Large-Scale Dairy Farms.” Drawing on an analysis of thousands of clinical cases from leading domestic dairy groups such as Yili and Modern Dairy, Pan highlighted that diseases in modern farms currently exhibit distinct seasonal patterns of high incidence. He emphasized that farms should develop and refine herd health management strategies—covering vaccination schedules as well as testing and monitoring intervals—in alignment with these epidemiological trends.

Regarding advances in research on emerging pathogens, he emphasized that bovine herpesvirus 4 (BoHV‑4), an emerging pathogen gaining increasing attention domestically, is significantly associated with reproductive disorders in dairy cattle. This pathogen exhibits high rates of nucleic acid and antibody positivity in Chinese cattle populations and poses a risk of maternal–fetal vertical transmission. Furthermore, the cross-host infection risk posed by border disease virus (BDV), as well as the mismatch between prevalent BVDV subtypes and existing vaccine strains, also warrant urgent vigilance. He stated that efforts should be strengthened to expand understanding of both established and emerging diseases, leveraging precise diagnostics to support the evaluation and optimization of vaccination programs and the upgrading of biosecurity systems, thereby effectively reducing disease risk and advancing the stepwise eradication of infectious diseases in cattle herds.

Li Jianxi, deputy director of the Lanzhou Institute of Animal Husbandry and Veterinary Medicine at the Chinese Academy of Agricultural Sciences, delivered a keynote report titled “Bovine Mammary Gland Prevention and Treatment Technologies.”

Li Jianxi, deputy director of the Lanzhou Institute of Animal Husbandry and Veterinary Medicine at the Chinese Academy of Agricultural Sciences, delivered a keynote report titled “Techniques for the Prevention and Control of Bovine Mastitis.” Li stated that over the past decade or so, the management of udder health in China’s cattle herds has improved significantly; however, subclinical mastitis, which presents with more subtle symptoms, remains a key challenge and focal point for the industry.

Li Jianxi analyzed that, in addition to common pathogens such as Streptococcus agalactiae, Staphylococcus aureus, and Escherichia coli causing mastitis, iatrogenic fungal infections resulting from equipment contamination are equally challenging and unresponsive to antibiotics. He emphasized that udder health depends not on a single treatment but on standardized implementation and continuous review, underscoring the urgent need to upgrade industry prevention and control models from “experience-based management” to “precision- and data-driven approaches.” This requires, on the one hand, strict adherence to three core testing and diagnostic principles—identifying the presence or absence of pathogens, determining the specific pathogen, and assessing whether medication is needed—and, on the other hand, deploying a comprehensive preventive strategy encompassing environmental hygiene, standardized milking practices, culling and herd cleansing, and precision medication.

Professor Li Shengli of China Agricultural University delivered a keynote report titled “Challenges Facing China’s Dairy Industry and Corresponding Measures.”

Professor Li Shengli of China Agricultural University delivered a keynote address titled “Challenges Facing China’s Dairy Industry and Corresponding Measures.” He noted that, starting in 2025, the global dairy sector is trending toward accelerated production growth alongside declining milk prices. Coupled with high oil prices, expectations of a strong El Niño event, and imported inflation risks, domestic milk prices are under significant external pressure. Looking back at the 14th Five-Year Plan period, China’s dairy industry has achieved remarkable results, with a clear trend toward larger-scale farms. However, he also pointed out that the industry continues to grapple with deep-seated issues, including four consecutive years of sluggish consumption, an imbalanced structure in dairy processing, and pronounced seasonal supply‑demand mismatches.

Based on the long-cycle patterns of the industry, Professor Li Shengli predicts that 2026 will mark the bottom and a turning point. In particular, the Ministry of Agriculture and Rural Affairs’ swift response this year to the Type I outbreak in South Africa has fully demonstrated the strategic reserves and emergency response capabilities of the national animal disease prevention and control system. He emphasized that for the industry to emerge from its downturn, both supply and demand must move in tandem, and he put forward four core recommendations for the 15th Five-Year Plan: first, stabilize production capacity by controlling overall volume, optimizing spatial distribution, and maintaining the size of the core breeding cow herd; second, boost consumption by vigorously developing emerging growth drivers such as cheese and whey protein; third, strengthen processing by advancing the fractionation of raw milk components and deep processing to address cyclical oversupply; and fourth, reduce costs by improving management practices and selective breeding across lactation stages, thereby comprehensively enhancing the industry’s resilience.

Zhang Xuezu, Vice President and Chief Technical Engineer of Modern Dairy (Group) Co., Ltd., delivered a keynote report titled “Key Strategies for Achieving Healthy and Efficient Future Development in China’s Dairy Industry.”

Zhang Xuezu, Vice President and Chief Technical Engineer of Modern Dairy (Group) Co., Ltd., delivered a keynote report titled “Key Pathways to Achieving Healthy and Efficient Development in China’s Dairy Industry.” He stated that dairy companies and farms have always maintained a closely intertwined, symbiotic relationship, while farms and suppliers form a collaborative partnership based on mutual empowerment. In the face of a new reality in which low milk prices and meager farm profits may become the norm, the entire industry should work together to establish mechanisms for aligned interests, and farms must break the impasse across four key dimensions.

On the production side, we prioritize dairy cow health as the fundamental basis for enhancing overall efficiency, leveraging innovative breeding to accelerate genetic improvement and build a high‑producing, resilient core herd of superior quality. On the management side, we are developing smart pastures that are highly digitalized and offer exceptional comfort, shifting from extensive management practices toward “precision control at the individual animal level” to fully unlock yield potential. On the business side, we continuously explore an efficiency‑driving model centered on milk production while diversifying operations, expanding into specialty functional milks and value‑added processed products to create a second growth trajectory for our farms and broaden profit margins. On the support side, by collaborating across the upstream and downstream segments of the industry chain, we are establishing eco‑pastures that integrate crop and livestock production in low‑carbon, circular systems, building professional management teams, and efficiently consolidating industry resources to lay a solid foundation for sustainable development.

Professor Zhou Yulong, Chief Scientist of the Province and professor at Heilongjiang Bayi Agricultural Reclamation University, delivered a keynote report titled “Building a Precision Prevention and Control System for Calf Diarrhea in the New Context.”

Zhou Yulong, a professor at Heilongjiang Bayi Agricultural Reclamation University and the province’s chief science and technology expert, delivered a keynote report titled “Building a Precision Prevention and Control System for Calf Diarrhea in the New Context.” Zhou pointed out that calf diarrhea, which is highly prevalent in winter and spring, is currently one of the most lethal group diseases in intensive dairy farms and is known in the industry as the “newborn calf killer.” Clinically, 75% to 95% of cases are caused by multiple pathogens, including rotavirus, coronavirus, and Escherichia coli. Moreover, bovine viral diarrhea virus type 2 (BVDV-2) exhibits even greater virulence, thereby placing higher demands on the development of multivalent vaccines and on comprehensive disease prevention and control strategies.

Zhou Yulong emphasized that calf diarrhea exhibits distinct onset windows and fecal characteristics depending on age and pathogen, allowing for rapid differentiation through three key observations: age, feces, and mucous membranes. He specifically cautioned that comprehensive prevention and control efforts must shift upstream to the rearing stage, implementing group housing and precision nutrition for calves, maintaining rigorous cleaning and disinfection across all phases as a foundational defense, standardizing core vaccination protocols for dams, closely monitoring passive immunity in calves, and strictly adhering to the principle of “early isolation and early treatment.” Through targeted medication and enhanced care, these measures can reduce calf mortality and farm losses.

Yang Hongjun, former deputy chief of the National Dairy Cattle Industry Technology System, delivered a keynote report titled “How Group Ranches Can Build Disease Prevention Systems and Achieve Pathogen Eradication.”

Yang Hongjun, former deputy chief of the National Dairy Cattle Industry Technology System, delivered a keynote report titled “How Group Farms Can Build Disease Prevention Systems and Achieve Eradication.” He noted that major dairy cattle diseases today often present as mixed infections, and most farms remain trapped in the biosecurity misconception of prioritizing external prevention while neglecting internal control. In light of the nation’s stringent new regulations on the prevention and control of major bovine diseases, the issues of indiscriminate vaccination and chaotic prevention protocols in group farms urgently require correction. He emphasized that scientific diagnosis is the prerequisite for disease prevention, vaccination is a crucial tool for disease control, and progressive eradication is the core strategy for breaking transmission chains.

Addressing the challenge of embryonic losses caused by vertical-transmission diseases such as brucellosis, Yang Hongjun stated that uncontrolled early abortions represent the biggest bottleneck to brucellosis eradication, and effective control of early abortions is essential to breaking the impasse. The “Progressive Eradication Method” pioneered by his team has been successfully implemented across 22 farms belonging to eight domestic corporate groups, helping one farm with over ten thousand cattle reduce its early abortion rate from a precipitous 40% to below 5%, thereby achieving both loss reduction and disease eradication. Moving forward, his team will continue to focus on research into key technologies for preventing and controlling vertically transmitted diseases, accelerating the deployment of a tiered eradication strategy encompassing “etiological diagnosis of early abortions—cattle grouping and isolation—standardized disinfection—adjustment of vaccination schedules—dynamic data collection and monitoring,” thus solidifying the foundation for healthy livestock farming.

Ran Zhiguang, Deputy General Manager of Aolong Bio, delivered a keynote report titled “Production Process of Aofu Binjing and Progress in the Development of Bovine Vaccines.”

Ran Zhiguang, Deputy General Manager of Aolong Bio, delivered a keynote presentation titled “Production Process of Aobu Binjing and Progress in the Development of Bovine Vaccines,” systematically outlining the company’s research achievements and advancements in the field of biological products for bovine diseases, and demonstrating its independent innovation capabilities in the systematic production and R&D of bovine vaccines.

He explained that the company’s core bovine product—the bivalent inactivated vaccine for bovine viral diarrhea/mucosal disease and infectious bovine rhinotracheitis (marketed as “Ao Fu Bi Jing,” strain NM01 + strain LN01/08)—has officially received a National New Veterinary Drug Registration Certificate (Category III) and a veterinary drug product approval number. This vaccine adheres to internal control standards that exceed national requirements and is manufactured using advanced processes, including green and efficient inactivation methods, providing ranches with a new tool for preventing and controlling viral diarrhea and infectious bovine rhinotracheitis.

In terms of R&D strategy, the company is currently focusing on five major challenges faced by dairy farms—cattle diarrhea, bovine respiratory disease complex (BRDC), reproductive disorders, and zoonotic diseases—and accelerating the development and production of multiple multivalent vaccines, including a bivalent inactivated vaccine against bovine rotavirus and coronavirus, as well as a bivalent inactivated vaccine targeting bovine herpesvirus 1 and bovine herpesvirus 4. Some of these products are expected to fill domestic gaps, providing dairy farms with more highly effective vaccines and comprehensive prevention-and-control solutions, thereby leveraging technological innovation to support the healthy development of the dairy industry.

Professor Li Shengli of China Agricultural University delivered a concluding address.

At the conclusion of the conference, Professor Li Shengli of China Agricultural University delivered a summarizing address. He reviewed the key points of each expert’s presentation and noted that the dairy industry is currently in a critical phase of deep restructuring and navigating economic cycles. “Prevention is better than cure; trading health for efficiency” has become the core principle for farms seeking to reduce costs and boost productivity, and it represents a shared consensus across the entire sector. This symposium focused on pressing issues related to major zoonotic diseases, including calf diarrhea, bovine respiratory disease complex (BRDC), and reproductive disorders. Covering topics from broader industry trends to farm management, biosecurity to eradication strategies, and clinical validation to vaccine products, the event offered systematic solutions addressing critical areas such as clinical epidemiology research, precision feeding and management, biosecurity system development, and vaccine-based immunization. The content was substantive, directly relevant, and of significant value to the industry, providing robust practical guidance.

Focusing on practical measures for disease prevention and control on farms, Professor Li Shengli emphasized three key requirements: First, move the defense line forward and firmly safeguard the bottom line. Especially during this critical window of industry recovery, it is essential to strengthen defenses against major diseases such as foot-and-mouth disease, brucellosis, and tuberculosis; current winter–spring vaccination efforts allow for no slackness or complacency. Second, implement precise strategies and let data guide decisions. We must resolutely break away from the habitual reliance on experience-based medication; clinical symptoms must never replace laboratory confirmation. Samples must be submitted for testing when required, and monitoring must be sustained, using objective data to provide scientific support for clinical decision-making. Third, accelerate disease eradication to gain the upper hand. Farms must prioritize disease eradication in their strategic agenda as soon as possible, rigorously enforcing “early monitoring, early isolation, early response” to maintain greater control amid cyclical challenges.

He called on the entire industry to remain confident and work in concert. Dairy farm partners, research institutes, and animal health companies should further deepen their “industry–university–research–application” collaboration, using science-based disease prevention to safeguard the dairy sector’s safety and healthy herds to deliver high-quality milk. Together, they should promote the steady and sustainable development of China’s dairy cattle industry and jointly usher in a turning point for the Chinese dairy sector.

Alone we go fast; together we go far! While industry cycles present formidable challenges, they also serve as an essential catalyst for upgrading the sector and unlocking efficiency through refined management and sustainable productivity. Starting from this new vantage point, Aolong Bio will remain firmly focused on the pressing clinical needs at the frontline of animal husbandry, collaborate with partners across the value chain, uphold our defenses against disease, and work in concert to strengthen the foundation for the healthy development of the livestock industry.

Latest Blog

2026-11-09

Bringing Together Industry Expertise to Usher in a New Chapter for Dairy Enterprises — The Golden Key for Dairy Cows · Aolong Bio Special Seminar Was Successfully Held in Rongchang!

On November 6, the “Dairy Cow Golden Key · Aolong Bio Special Seminar,” co-hosted by the Dairy Cow Golden Key Technical Service Alliance and Chongqing Aolong Biological Products Co., Ltd., was grandly held in Rongchang, Chongqing, at the China Animal Husbandry Science and Technology City. With the theme “Gathering Industry Expertise to Usher in a New Chapter for Dairy Enterprises,” the seminar focused on pressing challenges in dairy production and featured in-depth discussions on cutting-edge theories, farm operations, precision disease prevention and control, disease eradication, biosecurity, and digital and intelligent transformation.

2026-09-22

Successfully passed COFCO Jiajiakang’s supplier audit! Aolong Bio joins forces with an industry giant to usher in a new chapter of quality‑driven collaboration.

Aolong Bio has successfully completed end-to-end dynamic verification and documentation review, passing this rigorous assessment with outstanding results and officially being added to COFCO Jiajiakang’s roster of qualified veterinary vaccine suppliers.

2026-09-21

United in Purpose, Hand in Hand for Mutual Success—The 2026 National Sheep Vaccine Distributors Conference Concluded Successfully!

Jointly Building Channels, Sharing Growth—The 2026 National Sheep Vaccine Distributor Empowerment Conference was successfully held in the third-floor grand conference room of Aolong Bio!